DAPK1 and cancer: We also evaluated cancer cell migration after modulation of DAPK1 in these cells, which decreased significantly in stable DAPK1-overexpressing MDA-T32 and BCPAP cells (p < 0.001 and p < 0.001, respectively, Figure 2d,e).